Todd Skaar is a Professor of Medicine in the Division of Clinical Pharmacology in the Indiana University School of Medicine. He did his graduate work in nutrition at the University of Wisconsin, lactation physiology at the Penn State University, and a postdoc in breast cancer drug resistance at the Lombardi Cancer Center at Georgetown University. Since joining the Division of Clinical Pharmacology at the Indiana University School of Medicine, his research has focused on the discovery and implementation of genomic predictors of drug response. More specifically, his studies are focused on identifying and functionally testing genetic variants in the drug metabolism genes that are associated with clinical drug efficacy and toxicity. They also include studies to identify miRNAs that contribute to the drug-induced and developmental changes in hepatic drug metabolism. He leads multiple pharmacogenomics implementation studies focused on identifying and overcoming the barriers to using pharmacogenomics to guide drug therapies. He is also a co-leader of the Cancer Prevention & Control Program of the Indiana University Simon Comprehensive Cancer Center and the Director of the Indiana Institute for Personalized Medicine. His research is funded by grants from the NIH NIGMS, NHGRI, and NCI. His work has been published in over 200 peer-reviewed articles. He received the Outstanding Mentor Award from the IU School of Medicine and was recognized by Web of Science as a “Highly Cited Researcher”.
Zerbe Professor of Pharmacoeconomics - 2023